You are here: Industry Insights > facility

News List

Lupin responds to US FDA’s OAI letter expressbpd
March 15, 2019
Lupin is in the process of sending further updates of its corrective actions to the US FDA and remains hopeful of a positive outcome
Allogene Therapeutics to build out facility for allogeneic CAR T treatments fiercepharma
February 24, 2019
Another CAR T production facility is slated for the U.S. as a biotech moves down the road with a bucket full of cash and a fist full of candidates. But unlike currently approved CAR T treatments, Allogene Therapeutics is looking to use donated T cells tha
AGC Triples U.S. Biopharma Production Capacity contractpharma
December 27, 2018
AGC Biologics has enhanced its production capacity of biopharmaceutical manufacturing services. The contract development and manufacturing organization (CDMO) plans to install an additional twelve 2,000L single-use
Rentschler Biopharma Buys U.S. Mfg. Site from Shire contractpharma
December 18, 2018
Rentschler Biopharma SE, a contract development and manufacturing organization for biopharmaceuticals, has signed an agreement to purchase a manufacturing facility from an affiliate Shire plc in Milford near Boston, MA.
Cambrex Expands Analytical Capabilities at High Point contractpharma
December 13, 2018
Cambrex Corp., a manufacturer of small molecule active pharmaceutical ingredients (APIs), and finished dosage forms, is investing $1 million at its High Point, NC site to add 1,300 sq.-ft.
NW Bio Announces Deal Worth $47M contractpharma
December 12, 2018
Northwest Biotherapeutics ("NW Bio”) has entered into agreements with a large multi-national corporation for a package transaction involving the Company's property located near Cambridge, UK.
Lonza to Establish Bio Mfg. Base in China contractpharma
December 12, 2018
Lonza entered an agreement with GE Healthcareunder which GE will deliver a biologics facility to Lonza in Guangzhou. The facility is part of a larger biomanufacturing initiative between GE Healthcare
BlueRock, McEwen Stem Cell Institute Expand Alliance contractpharma
December 10, 2018
BlueRock Therapeutics, an engineered cell therapy company, has expanded its ongoing strategic collaboration with the McEwen Stem Cell Institute at the University Health Network (UHN) in Toronto.
Baxter, Oasmia Ink Apealea Commercial Mfg. Pact pharmatimes
December 10, 2018
Oasmia Pharmaceutical AB signed a new five-year contract with Baxter BioPharma Solutions for global commercial manufacturing of Apealea.
Bayer Group Restructures contractpharma
December 03, 2018
The Bayer Group is restructuring its core life science businesses through a series of portfolio, efficiency and structural measures that will result in the reduction of approximately 12,000 jobs worldwide...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 16 17 Next page